Association of Residual Cancer Burden After Neoadjuvant Therapy and Event-Free Survival in Breast Cancer

被引：0
|
作者：
Huang Xiaomei [1 ]
Liu Zaiyi [2 ]
机构：
[1] Southern Med Univ, Sch Clin Med 2, Guangzhou, Peoples R China
[2] Guangdong Acad Med Sci, Dept Radiol, Guangdong Prov Peoples Hosp, 106 Zhongshan Er Rd, Guangzhou 510080, Peoples R China
来源：
JAMA ONCOLOGY | 2022年 / 8卷 / 04期
关键词：
D O I：
10.1001/jamaoncol.2021.7997
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：645 / 646
页数：1
相关论文
共 50 条
  • [41] Men With Breast Cancer Have Same Disease-Specific and Event-Free Survival as Women
    Frédéric Marchal
    Magalie Salou
    Christian Marchal
    Anne Lesur
    Emmanuel Desandes
    Annals of Surgical Oncology, 2009, 16
  • [42] Men With Breast Cancer Have Same Disease-Specific and Event-Free Survival as Women
    Marchal, Frederic
    Salou, Magalie
    Marchal, Christian
    Lesur, Anne
    Desandes, Emmanuel
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (04) : 972 - 978
  • [43] Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522 5
    Pusztai, L.
    Denkert, C.
    O'Shaughnessy, J.
    Cortes, J.
    Dent, R.
    Mcarthur, H.
    Kuemmel, S.
    Bergh, J.
    Park, Y. H.
    Hui, R.
    Harbeck, N.
    Takahashi, M.
    Untch, M.
    Fasching, P. A.
    Cardoso, F.
    Zhu, Y.
    Pan, W.
    Tryfonidis, K.
    Schmid, P.
    ANNALS OF ONCOLOGY, 2024, 35 (05) : 429 - 436
  • [44] Worse event-free and relapse-free survival in financially disadvantaged patients with breast cancer in South India
    Thumsi, J.
    Nataraj, M.
    Kavitha, M. L.
    Jadhav, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S80 - S81
  • [45] Use of Residual Cancer Burden index and pretreatment tumor characteristics to predict breast cancer response to neoadjuvant therapy
    Gopal, Purva
    Kruse, Barb
    Chagpar, Anees
    Sahoo, Sunati
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (04) : 661 - 661
  • [46] Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients
    Yau, Christina
    Osdoit, Marie
    van der Noordaa, Marieke
    Shad, Sonal
    Wei, Jane
    de Croze, Diane
    Harny, Anne-Sophie
    Lae, Marick
    Reyal, Fabien
    Sonke, Gabes S.
    Steenbruggen, Tessa G.
    van Seijen, Maartje
    Wesseling, Jelle
    Martin, Miguel
    del Monte-Millan, Maria
    Lopez-Tarruella, Sara
    Boughey, Judy C.
    Goetz, Matthew P.
    Hoskin, Tanya
    Gould, Rebekah
    Valero, Vicente
    Edge, Stephen B.
    Abraham, Jean E.
    Bartlett, John M. S.
    Caldas, Carlos
    Dunn, Janet
    Earl, Helena
    Hayward, Larry
    Hiller, Louise
    Provenzano, Elena
    Sammut, Stephen-John
    Thomas, Jeremy S.
    Cameron, David
    Graham, Ashley
    Hail, Peter
    Mackintosh, Lorna
    Fan, Fang
    Godwin, Andrew K.
    Schwensen, Kelsey
    Sharma, Priyanko
    DeMichele, Angela M.
    Cole, Kimberly
    Pusztai, Lajos
    Kim, Mi-Ok
    Veer, Laura J. van't
    Esserman, Laura J.
    Symmans, W. Fraser
    LANCET ONCOLOGY, 2022, 23 (01): : 149 - 160
  • [47] Correlation between pathologic complete response, event-free survival/disease-free survival and overall survival in neoadjuvant and/or adjuvant HR+/HER2-breast cancer
    Gogate, Anagha
    Ranjan, Sandip
    Kumar, Amit
    Bhandari, Hitesh
    Papademetriou, Eros
    Kim, Inkyu
    Potluri, Ravi
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [48] A novel event-free survival endpoint in locally advanced pancreatic cancer
    Hammel, Pascal
    Carrier, Ewa
    Carney, Mairead
    Eisner, Mark
    Fleming, Thomas
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [49] Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Cancer Evaluated by Residual Cancer Burden, Neoadjuvant Response Index, and Neo-Bioscore
    Steenbruggen, Tessa G.
    van Seijen, Maartje
    Janssen, LiseloreM.
    van Ramshorst, Mette S.
    van Werkhoven, Erik
    Peeters, Marie-Jeanne T. D. F. Vrancken
    Wesseling, Jelle
    Lips, Esther H.
    Sonke, Gabe S.
    CLINICAL CANCER RESEARCH, 2019, 25 (16) : 4985 - 4992
  • [50] A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+Breast Cancer
    Miglietta, Federica
    Ragazzi, Moira
    Fernandes, Bethania
    Griguolo, Gaia
    Massa, Davide
    Girardi, Fabio
    Bottosso, Michele
    Bisagni, Alessandra
    Zarrilli, Giovanni
    Porra, Francesca
    Iannaccone, Daniela
    Dore, Leocadia
    Gaudio, Mariangela
    Santandrea, Giacomo
    Fassan, Matteo
    Lo Mele, Marcello
    De Sanctis, Rita
    Zambelli, Alberto
    Bisagni, Giancarlo
    Guarneri, Valentina
    Dieci, Maria Vittoria
    CLINICAL CANCER RESEARCH, 2023, 29 (17) : 3429 - 3437
12345